Company data sheet · Express Scripts Holding
Express Scripts Holding: left behind by its peers.
- Industry
- Drug Stores and Proprietary Stores
- Headquarters
- United States
- Sources
- SEC filings (2011–2019), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
- Data as of
- November 1, 2026
- Left behind by its peers. From 2016 to 2017, its revenue grew 0% in US dollars; the median among 64 large retailers grew 5%. It outgrew only 17% of them.
- A steady bench. Express Scripts Holding filed 12 leadership changes since 2016, fewer than 80% of large retailers (the median is 25).
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2016 | $100 billion | $3.4 billion | |
| 2017 | $100 billion | $4.5 billion |
As reported in its annual filings. Losses in red.
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Market reaction to disclosed decisions: 24 decision filings since 2016, each linked to the SEC, with the share return against its sector and the US market the next day and the next year (0 with market data).
- Economic context: 7 measures for the United States, every year since 2016, from the official sources.
- Peer comparison: against 71 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.